tirzepatide and celiac disease Did you know that one in 100 people in the U.S. are affected by disease? Tune in to our latest podcast episode with Dr. Jose Parungao, gastroenterologist, to learn about this tirzepatide and celiac disease Celiac

One of the biggest GLP-1 price factors is whether or not your insurance plan covers the medication

Miyasato Y, Oba K, Yasuno S, Matsuyama Y, Masuda I

AT contributed in creating the figures and in the critical revision of the manuscript

Gottshall, B

Myers, K

Disproportionality signals for IGE All five GLP-1RAs had statistically significant reporting odds ratios (RORs) for IGE: Semaglutide: ROR 24.8 Dulaglutide: ROR 14.7 Liraglutide: ROR 13.7 Exenatide: ROR 5.4 Tirzepatide: ROR 18.3 This analysis confirms that these drugs are significantly more likely to be reported in conjunction with IGE compared to other medications